Work

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade

Year: 2021
Type: editorial
Abstract: Sequential combination of immunogenic cell death (ICD)-induced interventions with subsequent immunotherapy has shown efficacy in preclinical models and clinical evaluation. Recently, a clinical trial enrolling small cell lung cancer patients treated with amrubicin together with PD-1 blockade confirmed the notion that ICD sensitizes tumors to immune checkpoint inhibitors.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,913
OpenAlex ID: W3211098331
Cites: 25
Cited by: 17
Related to: 10